Matthias Miller
Mannheim, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Radiotherapy orchestrates natural killer cell dependent antitumor immune responses through CXCL8.
Journal: Science advances
Published: March 23, 2022
KIR downregulation by IL-12/15/18 unleashes human NK cells from KIR/HLA-I inhibition and enhances killing of tumor cells.
Journal: European journal of immunology
Published: May 12, 2017
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer.
Journal: Nature
Published: January 30, 2017
MicroRNA-519a-3p mediates apoptosis resistance in breast cancer cells and their escape from recognition by natural killer cells.
Journal: Cell death & disease
Published: November 28, 2016
Mechanisms of efficacy in cancer immunotherapy: 14th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Mainz, Germany, May 10-12, 2016.
Journal: Cancer immunology, immunotherapy : CII
Published: September 14, 2016
Adoptively transferred natural killer cells maintain long-term antitumor activity by epigenetic imprinting and CD4+ T cell help.
Journal: Oncoimmunology
Published: April 04, 2016
The right patient for the right therapy: 13th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Mainz, Germany, May 11-13, 2015.
Journal: Cancer immunology, immunotherapy : CII
Published: February 26, 2016
Highly efficient IL-21 and feeder cell-driven ex vivo expansion of human NK cells with therapeutic activity in a xenograft mouse model of melanoma.
Journal: Oncoimmunology
Published: January 27, 2016
The HMGB1 protein induces a metabolic type of tumour cell death by blocking aerobic respiration.
Journal: Nature communications
Published: November 03, 2015
Exploiting natural killer cells for therapy of melanoma.
Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
Published: February 03, 2015
Toward the next generation of NK cell-based adoptive cancer immunotherapy.
Journal: Oncoimmunology
Published: January 28, 2013
Sustained effector function of IL-12/15/18-preactivated NK cells against established tumors.
Journal: The Journal of experimental medicine
Published: December 05, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026